Heart and Vascular
MARITIME-HF
Cardiometabolic
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Contact Research Team:
[email protected]
Site principal investigator:
Andrew Sauer, MD
Learn more about this study:
NCT07037459